Detalhe da pesquisa
1.
Neutralizing Antibody Kinetics and Immune Protection Against Herpes Simplex Virus 1 Genital Disease in Vaccinated Women.
J Infect Dis
; 227(4): 522-527, 2023 02 14.
Artigo
Inglês
| MEDLINE | ID: mdl-35199165
2.
Cross-Reactive Antibody Responses to Novel H5Nx Influenza Viruses Following Homologous and Heterologous Prime-Boost Vaccination with a Prepandemic Stockpiled A(H5N1) Vaccine in Humans.
J Infect Dis
; 216(suppl_4): S555-S559, 2017 09 15.
Artigo
Inglês
| MEDLINE | ID: mdl-28934456
3.
Safety and Immunogenicity of a Subvirion Monovalent Unadjuvanted Inactivated Influenza A(H3N2) Variant Vaccine in Healthy Persons ≥18 Years Old.
J Infect Dis
; 212(4): 552-61, 2015 Aug 15.
Artigo
Inglês
| MEDLINE | ID: mdl-25649171
4.
Safety and Immunogenicity of a Single Low Dose or High Dose of Clade 2 Influenza A(H5N1) Inactivated Vaccine in Adults Previously Primed With Clade 1 Influenza A(H5N1) Vaccine.
J Infect Dis
; 212(4): 525-30, 2015 Aug 15.
Artigo
Inglês
| MEDLINE | ID: mdl-25712967
5.
Effect of Varying Doses of a Monovalent H7N9 Influenza Vaccine With and Without AS03 and MF59 Adjuvants on Immune Response: A Randomized Clinical Trial.
JAMA
; 314(3): 237-46, 2015 Jul 21.
Artigo
Inglês
| MEDLINE | ID: mdl-26197184
6.
Correlate of immune protection against HSV-1 genital disease in vaccinated women.
J Infect Dis
; 209(6): 828-36, 2014 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-24285844
7.
HSV-1 and HSV-2 seroprevalence in the united states among asymptomatic women unaware of any herpes simplex virus infection (Herpevac Trial for Women).
South Med J
; 107(2): 79-84, 2014 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-24926671
8.
Serological responses to an avian influenza A/H7N9 vaccine mixed at the point-of-use with MF59 adjuvant: a randomized clinical trial.
JAMA
; 312(14): 1409-19, 2014 Oct 08.
Artigo
Inglês
| MEDLINE | ID: mdl-25291577
9.
Immunogenicity of avian influenza A/Anhui/01/2005(H5N1) vaccine with MF59 adjuvant: a randomized clinical trial.
JAMA
; 312(14): 1420-8, 2014 Oct 08.
Artigo
Inglês
| MEDLINE | ID: mdl-25291578
10.
Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women.
Clin Infect Dis
; 56(3): 344-51, 2013 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-23087395
11.
An Oil-in-Water adjuvant significantly increased influenza A/H7N9 split virus Vaccine-Induced circulating follicular helper T (cTFH) cells and antibody responses.
Vaccine
; 40(49): 7065-7072, 2022 11 22.
Artigo
Inglês
| MEDLINE | ID: mdl-36273986
12.
An evaluation of cytokine and cellular immune responses to heterologous prime-boost vaccination with influenza A/H7N7-A/H7N9 inactivated vaccine.
Hum Vaccin Immunother
; 16(12): 3138-3145, 2020 12 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32401699
13.
High dose trivalent influenza vaccine compared to standard dose vaccine in patients with rheumatoid arthritis receiving TNF-alpha inhibitor therapy and healthy controls: Results of the DMID 10-0076 randomized clinical trial.
Vaccine
; 38(23): 3934-3941, 2020 05 13.
Artigo
Inglês
| MEDLINE | ID: mdl-32295718
14.
Baseline Levels of Influenza-Specific B Cells and T Cell Responses Modulate Human Immune Responses to Swine Variant Influenza A/H3N2 Vaccine.
Vaccines (Basel)
; 8(1)2020 Mar 13.
Artigo
Inglês
| MEDLINE | ID: mdl-32183105
15.
Correlation between herpes simplex virus neutralizing antibody titers determined by ELVIS cell and traditional plaque reduction assays.
PLoS One
; 14(4): e0214467, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-30946751
16.
Safety and immunogenicity of an 8 year interval heterologous prime-boost influenza A/H7N7-H7N9 vaccination.
Vaccine
; 37(19): 2561-2568, 2019 05 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30955980
17.
Safety and immunogenicity of unadjuvanted subvirion monovalent inactivated influenza H3N2 variant (H3N2v) vaccine in children and adolescents.
Vaccine
; 37(36): 5161-5170, 2019 08 23.
Artigo
Inglês
| MEDLINE | ID: mdl-31375440
18.
Safety and immunogenicity of investigational seasonal influenza hemagglutinin DNA vaccine followed by trivalent inactivated vaccine administered intradermally or intramuscularly in healthy adults: An open-label randomized phase 1 clinical trial.
PLoS One
; 14(9): e0222178, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-31532789
19.
DNA vaccine priming for seasonal influenza vaccine in children and adolescents 6 to 17 years of age: A phase 1 randomized clinical trial.
PLoS One
; 13(11): e0206837, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-30388160
20.
Safety and efficacy of a cytomegalovirus glycoprotein B (gB) vaccine in adolescent girls: A randomized clinical trial.
Vaccine
; 34(3): 313-9, 2016 Jan 12.
Artigo
Inglês
| MEDLINE | ID: mdl-26657184